They further revealed that IDC-P and CA were significantly associated with a “nimbosus” phenomenon of prostate cancer, which is characterized by an increased percentage of genome alteration (median 7.2 vs. 3.0%), hypoxia (64.0% vs. 45.5%), and long noncoding RNA SChLAP1 (SWI/SNF complex antagonist associated with prostate cancer 1) abundance (>3-fold higher expression) [10]. This evidence concerns the gene SCHLAP1 and prostate carcinoma.